Dr Benjamin Goudey
AI Technical Lead, Australian Biocommons
Australian Biocommons
88 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Sex and APOE ε4 genotype modify risk factor associations with cerebral amyloid angiopathy: a multi-cohort autopsy study
DOI: 10.1186/s13195-025-01948-82026
Journal article
Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease
DOI: 10.1093/ageing/afag2632026
Journal article
Comparing pathway-informed polygenic risk score strategies on a multi-cohort evaluation of amyloid-β positivity
DOI: 10.1038/s41598-026-66621-y2026
Journal article
Neuropathological and vascular determinants of cerebral amyloid angiopathy risk: evidence from the NACC cohort
DOI: 10.1186/s13195-026-02064-x2026
Journal article
Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's disease
DOI: 10.1016/j.ebiom.2026.1063292026
Journal article
Fine-Mapping of HLA Effects in Oral and Non-Oral Lichen Planus
DOI: 10.1111/tan.708092026
Research contracts (non-grants)
All of Us Institutional Data Use and Registration Agreement
RECENT SCHOLARLY WORKS
2025
Journal article
Leveraging Routine Blood Tests, Plasma pTau-217, and Machine Learning for Enhanced Detection and Monitoring of Preclinical Alzheimer's Disease
DOI: 10.1002/alz70860_0971062025
Journal article
Proteomic analysis of brain and spinal cord tissue reveals distinct immune and mitochondrial processes between human and mouse ALS models
DOI: 10.1038/s41598-025-11466-02025
Journal article
Development and validation of an interpretable clinical scoring model to monitor the progression of preclinical Alzheimer’s disease
DOI: 10.1186/s13195-025-01931-32025
Journal article
Predicting severity of cerebral amyloid angiopathy neuropathology: A modeling approach using NACC and ROSMAP data
DOI: 10.1002/alz.70057